Search

Search Constraints

You searched for: Author/Creator Diamantopoulos, Panagiotis

Search Results

1. A case report of a very late response to 5-azacytidine in a patient with lower risk myelodysplastic syndrome: Time to update treatment guidelines for lower risk patients. Issue 17 (April 2018)

3. A clinical audit of nutritional screening and support of hospitalized patients with hematologic diseases. (April 2018)

5. Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group. (August 2018)

6. Bullous Pemphigoid–like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature. Issue 3 (April 2018)

8. Cytomegalovirus Infections in Patients Treated With Immune Checkpoint Inhibitors for Solid Malignancies. (28th March 2023)

9. Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group. Issue 1 (January 2020)

10. Endocrine‐related adverse events associated with immune‐checkpoint inhibitors in patients with melanoma. (13th September 2019)